Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

50%

2 trials in Phase 3/4

Results Transparency

67%

2 of 3 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A
2(50.0%)
Phase 4
2(50.0%)
4Total
N/A(2)
Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT03817931Phase 4Completed

Higher Neural Changes Following Anticholinergic, Beta 3 Agonist, or Placebo in Patients With Overactive Bladder

Role: collaborator

NCT03493126Phase 4Completed

Vaginal Estrogen on Postpartum Atrophy, Perineal Pain, and Sexual Function

Role: collaborator

NCT02888093Not ApplicableCompleted

A Randomized Controlled Trial of Permanent vs Absorbable Suture for Uterosacral Ligament Suspension

Role: collaborator

NCT01940367Not ApplicableUnknown

Electrical Nerve Stimulation for Overactive Bladder a Comparison of Treatments

Role: collaborator

All 4 trials loaded